Schwind Announces 825,000 Treatments Performed With No-Touch Eye Laser Treatment

Schwind announced that more than 825,000 no-touch eye laser treatment treatments have been performed so far.

SmartSurfACE, the proprietary TransPRK procedure from Schwind, continues to grow rapidly. Using TransPRK or SmartSurfACE, the eye and the cornea are not touched with any instrument. This distinguishes the Schwind procedure from other common methods of correcting visual deficiencies.

Launched in 2009, the TransPRK treatment with the Schwind AMARIS Excimer laser corrects visual deficiencies gently and in one step, without suction of the eye, flap or incision, and without the use of alcohol. Treatment takes place directly on the upper surface of the cornea. There are no cut or flap complications. This noninvasive method leaves a very stable cornea with highly precise outcomes, and thus provides more safety for the patient, according to a company news release. The expertise of eye surgeons using TransPRK is also reflected in scientific journal articles including experiences and clinical outcomes with the no touch eye laser treatment. TransPRK has proven its efficacy in more than 40 peer reviewed publications.

The key advantage of SmartSurfACE is the combination of the TransPRK surface ablation method and the SCHWIND SmartPulse Technology introduced in 2015. SmartPulse allows the laser pulses to be arranged optimally and positioned more closely than before. This leads to optimum vision quality in the early postoperative phase, and significantly faster healing.